Dallas Fort Worth Injury Lawyer Blog

DePuy ASR metal on metal hip implant recipients in states with a 2 year Statute of Limitations, may lose their rights to file a lawsuit if they do not file their lawsuit before August 23, 2012. J&J’s DePuy unit recalled its 93,000 ASR hips worldwide in 2010, including 37,000 in the U.S., saying more than 12 percent of the devices failed within five years. Over 6,000 lawsuits in federal and state courts describe patients in pain and immobilized by joint dislocations, infections and bone fractures.

What is Statute of Limitations?

Every state has a law called the statute of limitations (SOL) that sets a limited time period in which a lawsuit can be filed. The reason for this law is that the courts want to have a finite time for folks to bring claims and not have an unending litigation time period. If a person with a legal claim fails to have a lawsuit filed within this time period, then their claim can be forever lost.

What is Infuse?

The Medtronic Infuse bone graft is a genetically engineered liquid protein that helps the body to grow its own bone. It includes a bioengineered protein manufactured by Wyeth, called bone morphogenetic protein (BMP).

Scope of the Infuse Problem

According to attorneys, DePuy ASR hip implants which were recalled by the company in 2010, will start going to trial later this year to help determine liability and damages in more than 6,000 lawsuits.

J&J’s DePuy unit recalled its 93,000 ASR hips worldwide in 2010, including 37,000 in the U.S. According to medical experts, more than 12 percent of the devices failed within five years.

According to the allegations raised in lawsuits, filed in federal and state courts, patients are in pain and immobilized by joint dislocations, infections, bone fractures, and a medical condition known as metallosis.

The Biomet M2a-Magnum hip implant is the latest metal-on-metal hip device to come under scrutiny following reports of a wide range of adverse side effects associated with it.

What is Biomet M2A-Magnum Hip?

The Biomet M2A-Magnum Hip is a metal-on-metal hip replacement system that has been implanted in patients throughout the United States.

A Tennessee man has filed a lawsuit against the maker of Pradaxa, claiming that the blood thinner caused him to suffer a cerebral hemorrhage.

According to the complaint, Boehringer Ingelheim Pharmaceuticals, Inc. concealed knowledge that Pradaxa can cause serious, life-threatening bleeds, and did not warn that Pradaxa bleeding side effects may be irreversible.

The plaintiff alleges that he was prescribed Pradaxa, and after 2 months of use, he suffered a cerebral hemorrhage, as well as other severe personal injuries which are permanent in nature.

According to Bayer AG, the German pharmaceutical giant has shelled out $142 million so far, in settlements of U.S. lawsuits claiming that its Yaz, Yasmin and Ocella line of birth-control pills caused blood clots.

Bayer, said today in its Stockholders’ Newsletter for the first quarter, that it has resolved 651 cases alleging its Yasmin and Yaz contraceptives caused blood clots that can lead to heart attacks, deep vein thrombosis, pulmonary embolism and strokes.

The company said it paid $142 million in the settlements, for an average of about $218,000 a case.